Biotherapeutic targets for the treatment of allergic airway disease

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 4 II, 2000, Pages

  Coyle, Anthony J ^a   Lloyd, Clare M ^a,b   Gutierrez Ramos, Jose Carlos ^a  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR; IMMUNOGLOBULIN E ANTIBODY;

ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ASTHMA; CELL DIFFERENTIATION; CELL MIGRATION; CONFERENCE PAPER; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0033762681     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.supplement_3.15tac8     Document Type: Conference Paper

References (46)

1. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production
2. Eosinophilia in transgenic mice expressing interleukin 5
3. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma
4. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs
5. IL-4 is required for the induction of mucosal Th2 immunity
6. Interleukin 5 deficiency abolishes eosinophilia, airways hyperre-activity, and lung damage in a mouse asthma model
7. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
8. Eosinophils are not required to induce airway hyperresponsiveness after nematode infection
9. 55700, A humanized monoclonal antibody to human interleukin-5, on eosinophilic responses and bronchial hyperreactivity
10. The murine IL-13 receptor alpha 2: Molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1
11. Disruption of the murine IL-4 gene blocks Th2 cytokine responses
12. CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production
13. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: Lymphocytic and eosinophilic inflammation without airway hyperreactivity
14. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses
15. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
16. Interleuktn-13: Central mediator of allergic asthma
17. Interleukin-4 receptor in moderate atopic asthma: A phase I/II randomized, placebo-controlled trial
18. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness
19. Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction
20. Demonstration of the therapeutic potential of non-anaphylactogenic anti-IgE antibodies in murine models of skin reaction, lung function and inflammation
21. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: Inhibition by a non-anaphylactogenic anti-IgE antibody
22. Low-affinity IgE receptor (CD23) function on mouse B cells: Role in IgE-dependent antigen focusing
23. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects
24. Treatment of allergic asthma with monoclonal anti-IgE antibody: RhuMAb-E25 Study Group
25. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice
26. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma
27. Mouse eotaxin expression parallels eosinophil accumulatien during lung allergic inflammation but it is not restricted to a Th2-type response
28. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: Relationship to eosinophil, T cell, and macrophage recruitment
29. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness
30. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia
31. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation
32. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
33. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs
34. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells
35. Flexible programs of chemokine receptor expression on human polarized T helper 1 and lymphocytes
36. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo
37. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells
38. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells
39. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 function
40. T1/ST2 plays a critical role in Th2 cell function and regulates allergen induced lung pathology and airway hyperresponsiveness
41. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
42. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus re-stimulation of Th2 but not Th1 cytokine production
43. OX-40 deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection
44. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus
45. ICOS is an inducible Tcell co-stimulator structurally and functionally related to CD28
46. T-cell co-stimulation through B7RP-1 and ICOS